BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 24390232)

  • 1. XRCC1 Arg399Gln genetic polymorphism and the risk of hepatocellular carcinoma: a meta-analysis.
    Qi Y; Cui L; Song Y; Li N
    Mol Biol Rep; 2014 Feb; 41(2):879-87. PubMed ID: 24390232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphisms of DNA repair gene XRCC1 and hepatocellular carcinoma risk among East Asians: a meta-analysis.
    Li J; Li Z; Feng L; Guo W; Zhang S
    Tumour Biol; 2013 Feb; 34(1):261-9. PubMed ID: 23055199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. XRCC1 genetic polymorphism Arg399Gln and hepatocellular carcinoma risk: a meta-analysis.
    Liu F; Li B; Wei Y; Yan L; Wen T; Zhao J; Xu M
    Liver Int; 2011 Jul; 31(6):802-9. PubMed ID: 21645210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. X-ray repair cross-complementing group 1 Arg399Gln gene polymorphism and susceptibility to colorectal cancer:a meta-analysis.
    Zeng FR; Ling Y; Yang J; Tian XC; Yang X; Luo RC
    Tumour Biol; 2013 Feb; 34(1):555-63. PubMed ID: 23188703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between XRCC1 Arg399Gln polymorphism and hepatitis virus-related hepatocellular carcinoma risk in Asian population.
    Wu D; Jiang H; Gu Q; Zhang D; Li Z
    Tumour Biol; 2013 Oct; 34(5):3265-9. PubMed ID: 23780894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An updated meta-analysis on the association of X-ray repair cross complementing group 1 codon 399 polymorphism with hepatocellular carcinoma risk.
    Wang YD; Zhai WL; Wang HY; Xia XQ
    Asian Pac J Cancer Prev; 2014; 15(11):4443-8. PubMed ID: 24969866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An updated meta-analysis between the association of XRCC1 Arg399Gln polymorphism and hepatocellular carcinoma risk.
    Zhang XL; Lu Y; Yang S; Peng QL; Wang J; Xie L; Deng Y; He Y; Li TJ; Qin X; Li S
    Asian Pac J Cancer Prev; 2014; 15(7):3273-8. PubMed ID: 24815482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. X-ray repair cross-complementing group 1 polymorphisms and hepatocellular carcinoma: a meta-analysis.
    Xie T; Wang ZG; Zhang JL; Liu H
    World J Gastroenterol; 2012 Aug; 18(31):4207-14. PubMed ID: 22919255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of X-ray repair cross complementing group 1 Arg399Gln polymorphisms with the risk of squamous cell carcinoma of the head and neck: evidence from an updated meta-analysis.
    Wang Y; Chu X; Meng X; Zou F
    PLoS One; 2013; 8(10):e77898. PubMed ID: 24205020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The XRCC1 Arg399Gln genetic polymorphism contributes to hepatocellular carcinoma susceptibility: an updated meta-analysis.
    Pan Y; Zhao L; Chen XM; Gu Y; Shen JG; Liu LM
    Asian Pac J Cancer Prev; 2013; 14(10):5761-7. PubMed ID: 24289575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. XRCC1 Arg399Gln variation and leukemia susceptibility: evidence from 2,647 cases and 5,518 controls.
    Huang Y; Xie D; Tang N; Wang J; Zeng X; Zhao P; He L
    Tumour Biol; 2014 Jan; 35(1):799-808. PubMed ID: 23990457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meta-analysis demonstrates no association between XRCC1 Arg399Gln polymorphism and bladder cancer risk.
    Dong LM; Zhang XY; Teng H; Li MS; Wang P
    Genet Mol Res; 2014 Nov; 13(4):9976-85. PubMed ID: 25501209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between the XRCC1 polymorphisms and glioma risk: a meta-analysis of case-control studies.
    Jiang L; Fang X; Bao Y; Zhou JY; Shen XY; Ding MH; Chen Y; Hu GH; Lu YC
    PLoS One; 2013; 8(1):e55597. PubMed ID: 23383237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of DNA repair gene XRCC1 polymorphism in prediction and prognosis of hepatocellular carcinoma risk.
    Li QW; Lu CR; Ye M; Xiao WH; Liang J
    Asian Pac J Cancer Prev; 2012; 13(1):191-4. PubMed ID: 22502666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Association Between the XRCC1 Arg399Gln Polymorphism and the Risk of Head and Neck Cancer: An Updated Meta-Analysis Including 14586 Subjects.
    Xia S; Wu S; Wang M
    Technol Cancer Res Treat; 2021; 20():15330338211033060. PubMed ID: 34278875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations between three XRCC1 polymorphisms and hepatocellular carcinoma risk: A meta-analysis of case-control studies.
    Xiong Y; Zhang Q; Ye J; Pan S; Ge L
    PLoS One; 2018; 13(11):e0206853. PubMed ID: 30408066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. XRCC1 Arg399Gln gene polymorphism and hepatocellular carcinoma risk in the Italian population.
    Santonocito C; Scapaticci M; Nedovic B; Annicchiarico EB; Guarino D; Leoncini E; Boccia S; Gasbarrini A; Capoluongo E
    Int J Biol Markers; 2017 May; 32(2):e190-e194. PubMed ID: 28058700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. X-ray repair cross-complementing group 1 (XRCC1) genetic polymorphisms and cervical cancer risk: a huge systematic review and meta-analysis.
    Li Y; Liu F; Tan SQ; Wang Y; Li SW
    PLoS One; 2012; 7(9):e44441. PubMed ID: 22984511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymorphism of XRCC1 (at codon 399) and susceptibility to breast cancer, a meta-analysis of the literatures.
    Saadat M; Ansari-Lari M
    Breast Cancer Res Treat; 2009 May; 115(1):137-44. PubMed ID: 18481169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. XRCC1 Arg399Gln gene polymorphism and hepatocellular carcinoma risk in the Chinese Han population: a meta-analysis.
    Duan WH; Zhu ZY; Liu JG; Dong MS; Chen JZ; Liu QD; Xie Y; Sun TY; Gao ZF; Zhou NX
    Asian Pac J Cancer Prev; 2012; 13(8):3601-4. PubMed ID: 23098440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.